# Study of ALGRX 3268 for Needlestick Pain in Children

> **NCT00132405** · PHASE2 · COMPLETED · sponsor: **AlgoRx Pharmaceuticals** · enrollment: 260 (—)

## Conditions studied

- Pain

## Interventions

- **DRUG:** ALGRX 3268

## Key facts

- **NCT ID:** NCT00132405
- **Lead sponsor:** AlgoRx Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** 2004-09
- **Target enrollment:** 260 (—)
- **Last updated:** 2005-10-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00132405

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00132405, "Study of ALGRX 3268 for Needlestick Pain in Children". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00132405. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*